{"id":1068471,"date":"2024-02-14T02:39:46","date_gmt":"2024-02-14T07:39:46","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/vaxxinity-to-present-clinical-and-preclinical-pipeline-data-at-ad-pd-2024\/"},"modified":"2024-08-18T11:47:43","modified_gmt":"2024-08-18T15:47:43","slug":"vaxxinity-to-present-clinical-and-preclinical-pipeline-data-at-ad-pd-2024","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/vaxxinity-to-present-clinical-and-preclinical-pipeline-data-at-ad-pd-2024.php","title":{"rendered":"Vaxxinity to Present Clinical and Preclinical Pipeline Data at AD\/PD 2024"},"content":{"rendered":"<p><![CDATA[CAPE CANAVERAL, Fla., Feb.  13, 2024  (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (Nasdaq: VAXX), a U.S. company pioneering the development of a new class of medicines, today announced it will present clinical data from its UB-312 program in Parkinson\u2019s disease and preclinical data from its anti-tau program in Alzheimer\u2019s disease at the International Conference on Alzheimer\u2019s and Parkinson\u2019s Diseases and related neurological disorders (AD\/PD 2024), taking place March 5-9, 2024 virtually and in Lisbon, Portugal.]]><\/p>\n<p>See original here:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2024\/02\/13\/2828226\/0\/en\/Vaxxinity-to-Present-Clinical-and-Preclinical-Pipeline-Data-at-AD-PD-2024.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Vaxxinity to Present Clinical and Preclinical Pipeline Data at AD\/PD 2024\">Vaxxinity to Present Clinical and Preclinical Pipeline Data at AD\/PD 2024<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>See original here: Vaxxinity to Present Clinical and Preclinical Pipeline Data at AD\/PD 2024 <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/vaxxinity-to-present-clinical-and-preclinical-pipeline-data-at-ad-pd-2024.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-1068471","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068471"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1068471"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068471\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1068471"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1068471"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1068471"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}